Kavar Capital Partners Group »

Amgen shares owned by Kavar Capital Partners Group

Quarter-by-quarter ownership of Amgen (AMGN) shares owned by Kavar Capital Partners Group from 13F filings

Historical chart of Kavar Capital Partners Group investment in Amgen

Tip: Access up to 7 years of quarterly data

All positions including Amgen held by Kavar Capital Partners Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amgen by Kavar Capital Partners Group

Quarter filed Position value Share count Share price at filing
2024-03-31 $299k 1.1k 284.32
2021-06-30 $205k 840 244.05

More positions owned by Kavar Capital Partners Group

Schwab Strategic Tr Schwab Fdt Us Lg (FNDX)
Apple (AAPL)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Schwab Strategic Tr Intl Eqty Etf (SCHF)
NVIDIA Corporation (NVDA)
Thermo Fisher Scientific (TMO)
Microsoft Corporation (MSFT)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Alphabet Cap Stk Cl A (GOOGL)
Danaher Corporation (DHR)
Procter & Gamble Company (PG)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
American Centy Etf Tr Us Sml Cp Valu (AVUV)
Abbvie (ABBV)
Caterpillar (CAT)

View all positions for Kavar Capital Partners Group

Top funds holding Amgen

Vanguard Group
BlackRock
PRIMECAP Management Company
Morgan Stanley
Geode Capital Management
Charles Schwab Investment Management
Wells Fargo & Company
Northern Trust
Royal Bank of Canada
Bank of New York Mellon
Barclays
Legal & General Group
Goldman Sachs Group
Reed Conner & Birdwell
FMR

View all funds holding Amgen